Research programme: hyaluronan mediated motility receptors targeted therapeutics - Novare Pharmaceuticals

Drug Profile

Research programme: hyaluronan mediated motility receptors targeted therapeutics - Novare Pharmaceuticals

Alternative Names: HMMR-protein-target - Novare Pharmaceuticals; Intracellular-hyaluronic-acid-binding-protein-target - Novare Pharmaceuticals; Receptors for hyaluronan mediated motility targeting therapeutics - Novare Pharmaceuticals; RHAMM-binding peptides-Novare Pharmaceuticals; RHAMM-protein-target - Novare Pharmaceuticals

Latest Information Update: 01 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator London Health Sciences Centre Research
  • Developer Novare Pharmaceuticals
  • Class Proteins
  • Mechanism of Action Hyaluronic acid modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Arthritis; Bronchopulmonary dysplasia; Idiopathic pulmonary fibrosis; Keloids; Scars

Most Recent Events

  • 30 Jul 2015 Lawson Health Research Institute has patent protection for composition of matter and use of RHAMM-binding peptides in USA
  • 07 Oct 2014 Novare Pharmaceuticals acquires Receptor for Hyaluronan-Mediated Motility (RHAMM) compounds from London Health Sciences Centre Research
  • 07 Oct 2014 Early research in Arthritis, Breast cancer, Bronchopulmonary dysplasia, Idiopathic pulmonary fibrosis, Keloids and Scars in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top